SCHEMBL16299526

SCHEMBL16299526

COc1ccc(C(c2ccc(C(C)C)cc2)c2[nH]c3ccccc3c2CCN)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 8/20 0.53
HTR6 P50406 3/20 0.43
HTR1D P28221 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
NR3C1 P04150 1/20 0.43
PGR P06401 1/20 0.43
NR3C2 P08235 1/20 0.43
AR P10275 1/20 0.43
MTNR1B P49286 5/20 0.41
MTNR1A P48039 4/20 0.41
CHRNB2 P17787 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
VDR P11473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16302691 0.81 HTR1D (0.51) CYP19A1HTR6HTR1DMAPTMTNR1B
SCHEMBL7749049 0.78 TBXAS1 (0.52) HTR6HTR1DKDM4EMAPTMTNR1B
SCHEMBL16302689 0.76 HTR1D (0.44) CYP19A1HTR6HTR1DMTNR1BMTNR1A
SCHEMBL7613059 0.75 KDM4E (0.64) HTR6HTR1DKDM4EMAPTKMT2A
SCHEMBL8947058 0.74 HTR6 (0.68) HTR6HTR1DKDM4EMAPTKMT2A
SCHEMBL9210352 0.74 HTR6 (0.50) HTR6HTR1DKDM4EMAPTKMT2A
SCHEMBL29128851 0.70 HTR6 (0.52) HTR6HTR1DKDM4EMAPTKMT2A
SCHEMBL21478112 0.68 HTR1D (0.50) HTR6HTR1DKDM4EMAPTKMT2A
SCHEMBL16299520 0.68 HTR1D (0.44) HTR6HTR1DMTNR1BMTNR1A
SCHEMBL4490559 0.68 CYP19A1 (0.42) CYP19A1HTR6MTNR1BMTNR1ACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871375-B1 CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER PTC THERAPEUTICS INC (US) 2012-02-29 EP disclosed
WO-2008127715-A1 CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES PTC THERAPEUTICS, INC. (US) 2008-10-23 WO disclosed